000			06183nam a22003615i 4500
001			233999
003			ES-VaUE
005			20221220020535.0
007			cr nn 008mamaa
008			100301s2003 xxu| s |||| 0|eng d
020			_a9781592593231
024	7		_a10.1385/1592593232 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
245	1	0	_aLung Cancer _bVolume 1: Molecular Pathology Methods and Reviews _cedited by Barbara Driscoll.
250			_a1st edition 2003
264		1	_aTotowa, NJ _bHumana Press _c2003
300			_a1 recurso en línea (XXI, 594 páginas) _b
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aMethods in Molecular Medicine _x1940-6037 _v74
505	0		_aCharacteristic Genetic Alterations in Lung Cancer -- Etiology and Classification of Lung Tumors -- Clinical and Biological Relevance of Recently Defined Categories of Pulmonary Neoplasia -- Molecular Epidemiology of Human Cancer Risk -- Neuroendocrine Phenotype of Small Cell Lung Cancer -- AIDS-Associated Pulmonary Cancers -- Molecular Abnormalities in Lung Cancer -- Abrogation of the RB-p16Tumor Suppressor Pathway in Human Lung Cancer -- Sensitive Detection of Hypermethylated p16INK4a Alleles in Exfoliative Tissue Material -- Role of Receptor Tyrosine Kinases in Lung Cancer -- Relationship of EGFR Signal-Transduction Modulation by Tyrosine Kinase Inhibitors to Chemosensitivity and Programmed Cell Death in Lung Cancer Cell Lines -- Detection of the Transcripts and Proteins for the Transforming Growth Factor-? Isoforms and Receptors in Mouse Lung Tumorigenesis Using In Situ Hybridization and Immunohistochemistry in Paraffin-Embedded Tissue Sections -- Alterations in the Expression of Insulin-Like Growth Factors and Their Binding Proteins in Lung Cancer -- Screening of Mutations in the ras Family of Oncogenes by Polymerase Chain Reaction-Based Ligase Chain Reaction -- Assays for Raf-1 Kinase Phosphorylation and Activity in Human Small Cell Lung Cancer Cells -- ?-Glutamylcysteine Synthetase in Lung Cancer -- Localization of Cyclooxygenase-2 Protein Expression in Lung Cancer Specimens by Immunohistochemical Analysis -- Non-RI Protocols for L-myc Allelotyping and Deletion Mapping of Chromosome 1p in Primary Lung Cancers -- Intercellular Adhesion Molecules (ICAM-1, VCAM-1, and LFA-1) in Adenocarcinoma of Lung -- MUC1 Expression in Lung Cancer -- Altered Surface Markers in Lung Cancer -- Prognostic Relevance of Angiogenic, Proliferative, and Apoptotic Factors in Lung Carcinomas -- Morphological Assessment of Apoptosis in Human Lung Cells -- [D-Arg6, D-Trp7,9, NmePhe8]-Substance P (6-11) Activates JNK and Induces Apoptosis in Small Cell Lung Cancer Cells via an Oxidant-Dependent Mechanism -- Isolation of Cells Entering Different Programmed Cell Death Pathways Using a Discontinuous Percoll Gradient -- Angiogenesis, Metastasis, and Lung Cancer -- Matrix Metalloproteinase Expression in Lung Cancer -- Vascular Endothelial Growth Factor Expression in Non-Small Cell Lung Cancer -- Regulation of Angiostatin Mobilization by Tumor-Derived Matrix Metalloproteinase-2 -- In Vitro and In Vivo Assays for the Proliferative and Vascular Permeabilization Activities of Vascular Endothelial Growth Factor (VEGF) and Its Receptor -- Detection of Telomerase Activity in Lung Cancer Tissues -- Analysis of Alterations in a Base-Excision Repair Gene in Lung Cancer -- Lung Cancer Model Systems -- Induction of Lung Cancer by Passive Smoking in an Animal Model System -- Metastatic Orthotopic Mouse Models of Lung Cancer -- Lung-Specific Expression of Mutant p53 as Mouse Model for Lung Cancer -- Use of Nucleotide Excision Repair-Deficient Mice as a Model For Chemically Induced Lung Cancer -- Nude Mouse Lung Metastases Models of Osteosarcoma and Ewing 's Sarcoma for Evaluating New Therapeutic Strategies -- Tumor-Specific Metastasis to Lung Using Reporter Gene-Tagged Tumor Cells -- Cultures of Surgical Material from Lung Cancers -- The Hollow Fiber Assay.
520			_aMolecular-based laboratory methods can help significantly in the diagnosis and treatment of lung cancer, a leading cause of death worldwide. In Lung Cancer, Volume 1: Molecular Pathology Methods and Reviews, leading physicians, scientists, and noted researchers review novel methods for determining the etiology of a variety of lung cancers and present readily reproducible techniques for examining the associated multitude of genetic abnormalities. The methods described make it possible to detect these alterations at the cellular, DNA, and protein levels, to study the development of lung cancer in vitro and in vivo-either in situ or in the form of metastases-and to test targeted therapies with detailed model systems. An animal models section gives explicit instructions for setting up and testing these systems, which are rarely described in the literature. A companion volume, Lung Cancer, Volume 2: Diagnostic and Therapeutic Methods and Reviews, concentrates on diagnosing lung cancer through molecular analysis of clinical samples and providing a variety of novel therapies. Comprehensive and informative, Lung Cancer, Volume 1: Molecular Pathology Methods and Reviews illuminates the etiology of lung cancer and provides reliable techniques for detecting the responsible genetic mutations at the cellular, DNA, and protein levels. Together, the two volumes constitute an unprecedented resource for those who wish to better understand how this disease is being diagnosed and treated and what novel techniques may be available to improve both processes.
700	1		_aDriscoll, Barbara _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9781489939128
776	0	8	_iPrinted edition: _z9780896039858
776	0	8	_iPrinted edition: _z9781489939111
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1385/1592593232 _z(usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
988			_aSpringer_Protocols_2003
999			_c233999 _d233999